English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy

Press release submission | Apr 28, 2018

TEXAS MEDICAL CENTER: A New Era for the Texas Medical Center

Press release submission | Apr 28, 2018

CLEVELAND CLINIC: New MS Guidelines Call for Treatment Sooner

Press release submission | Apr 28, 2018

MASSACHUSETTS GENERAL HOSPITAL: Imaging may allow safe tPA treatment of patients with unwitnessed strokes

Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar

Press release submission | Apr 27, 2018

MASSACHUSETTS GENERAL HOSPITAL: Study identifies overdose risk factors in youth with substance use disorders

Press release submission | Apr 27, 2018

TEXAS MEDICAL CENTER: Regaining a Sense of Smell

Press release submission | Apr 27, 2018

CLEVELAND CLINIC:Research Links Proper Sleep to Better Dietary Choices

Trending

Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth

+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program

Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’

Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’

  • 1
  • 2
  • 3
  • 4
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily